← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

A

$ Value

$0

Shares

7,224

Price

$0

Filed

Apr 23

Insider

Name

Maizel Ari

Title

Chief Commercial Officer

CIK

0002042289

Roles

Officer

Transaction Details

Transaction Date

2026-04-21

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

7,224

Footnotes

Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock. | Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date.

Filing Info

Accession No.

0001193125-26-174413

Form Type

4

Issuer CIK

0001579428

Maizel Ari's History

Date Ticker Type Value
2026-04-22 AXSM M $530K
2026-04-22 AXSM $1.4M
2026-04-22 AXSM M $0
2026-04-21 AXSM A $0
2026-02-26 AXSM A $0
2026-01-21 AXSM M $530K
2026-01-21 AXSM $1.4M
2026-01-21 AXSM M $0

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22